A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

Goldman Sachs has initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) based on multi-blockbuster, first-to-market ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

The Tasmanian wolf was the largest carnivorous marsupial declared extinct in the 20th century. Scientists have managed to ...

A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...

"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...

Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

RNAConnect, a pioneering life science reagent company, today announced new distribution agreements with CliniSciences, 2BScientific, and Dakewe Biotech. These partnerships mark a significant milestone ...

Check the time stamp on this data. Updated AI-Generated Signals for Avidity Biosciences Inc. (RNA) available here: RNA.

Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the ...